Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals)), By Region, Competitive Landscape, Forecasts, 2018 - 2025 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 24, 2018--The “Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals)), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.
The global pharmacokinetics services market size is expected to reach USD 1.2 billion by 2025, registering an 8.3% CAGR during the forecast period.
Rising adoption of pharmacokinetic and toxicology studies for determination of several parameters such as no-observed-effect levels (NOEL), human equivalent doses (HED) levels, and pharmacokinetic/pharmacodynamic (PK/PD) drivers are expected to fuel market growth.
Thorough understanding of the pharmacokinetic profile of a potential drug candidate plays a major role in the success of a drug discovery program. In addition to this, regulatory bodies have played a major role in the progress of this market through establishing defined guidelines for conducting PK studies. There are a substantial number of CROs engaged in conducting PK studies in accordance with relevant EMEA, ICH, FDA, GCP, and other regulatory guidelines.
Growing concern for effective implementation of PK services in the drug development process is anticipated to drive investments in this sector. Several conferences and certification courses are being conducted across the world to increase the understanding of various paradigms associated with pharmacokinetics application in clinical and preclinical drug development.
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Research Methodology
Chapter 3 Pharmacokinetics Services Market Variables, Trends & Scope
Chapter 4 Pharmacokinetics Services Market: Drug Type Estimates & Trend Analysis
Chapter 5 Pharmacokinetics Services Market: Regional Estimates & Trend Analysis, by Drug Type
Chapter 6 Competitive LandscapeEvotec AG Certara, L.P. Pacific BioLabs GVK Biosciences Private Limited Shanghai Medicilon Inc. Pharmaceutical Product Development, LLC Charles River Laboratories International, Inc. PAREXEL International Corporation Eurofins Scientific, Inc. Frontage Labs SGS SA LGC Limited Creative Bioarray
For more information about this report visit https://www.researchandmarkets.com/research/cfx7vk/pharmacokinetics?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180824005214/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Drug Discovery
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/24/2018 09:26 AM/DISC: 08/24/2018 09:26 AM